Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.

PubWeight™: 1.91‹?› | Rank: Top 3%

🔗 View Article (PMID 20643091)

Published in Vaccine on July 17, 2010

Authors

Beate Sander1, Chris T Bauch, David Fisman, Robert A Fowler, Jeffrey C Kwong, Andreas Maetzel, Allison McGeer, Janet Raboud, Damon C Scales, Marija Zivkovic Gojovic, Murray Krahn

Author Affiliations

1: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. beate.sander@oahpp.ca

Articles citing this

Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2. Value Health (2012) 1.16

Pandemic (H1N1) 2009: assessing the response. CMAJ (2010) 1.11

Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PLoS One (2012) 1.11

Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study. PLoS One (2012) 0.98

Patterns of spread of influenza A in Canada. Proc Biol Sci (2013) 0.98

Canada in the face of the 2009 H1N1 pandemic. Influenza Other Respir Viruses (2010) 0.96

Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS One (2011) 0.94

Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ (2012) 0.93

Estimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada. PLoS One (2011) 0.93

Critical care services and the H1N1 (2009) influenza epidemic in Australia and New Zealand in 2010: the impact of the second winter epidemic. Crit Care (2011) 0.89

Socioeconomic status and other related factors of seasonal influenza vaccination in the South Korean adult population based on a nationwide cross-sectional study. PLoS One (2015) 0.79

Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. PLoS One (2015) 0.76

Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity. BMC Infect Dis (2011) 0.76

Economic evaluation of vaccines in Canada: A systematic review. Hum Vaccin Immunother (2016) 0.76

Cost-effectiveness of Ontario's pandemic vaccine program. Vaccine (2010) 0.75

Economic Evaluation of Health Services Costs During Pandemic Influenza A (H1N1) Pdm09 Infection in Pregnant and Non-Pregnant Women in Spain. Iran J Public Health (2016) 0.75

Is a Mass Prevention and Control Program for Pandemic (H1N1) 2009 Good Value for Money? Evidence from the Chinese Experience. Iran J Public Health (2012) 0.75

Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada. PLoS One (2017) 0.75

Economic evaluations of vaccines in Canada: a scoping review. Cost Eff Resour Alloc (2017) 0.75

Articles by these authors

Transmission dynamics and control of severe acute respiratory syndrome. Science (2003) 14.70

Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00

Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85

Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA (2009) 9.41

Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA (2007) 6.09

Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA (2009) 6.06

Critical care and the global burden of critical illness in adults. Lancet (2010) 5.55

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis (2007) 5.39

Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis (2013) 5.37

Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med (2014) 5.17

Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med (2008) 5.06

Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med (2014) 4.79

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet (2010) 4.53

Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother (2004) 4.46

Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer. J Clin Oncol (2014) 4.31

Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ (2003) 3.96

Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis (2009) 3.86

Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis (2006) 3.80

Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis (2010) 3.42

An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med (2002) 3.39

A multifaceted intervention for quality improvement in a network of intensive care units: a cluster randomized trial. JAMA (2011) 3.08

Patient and healthcare professional factors influencing end-of-life decision-making during critical illness: a systematic review. Crit Care Med (2011) 3.07

West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03

Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Respir Viruses (2009) 2.69

Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting. CMAJ (2011) 2.67

Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA (2011) 2.67

Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63

A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care (2005) 2.62

Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61

Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis (2005) 2.59

Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999. J Infect Dis (2002) 2.57

Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ (2005) 2.50

Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A (2010) 2.43

Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol (2003) 2.42

Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept study. Clin Infect Dis (2014) 2.37

Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A (2004) 2.32

Variation in use of intensive care for adults with diabetic ketoacidosis*. Crit Care Med (2012) 2.24

A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med (2009) 2.17

Ebola virus disease among children in West Africa. N Engl J Med (2015) 2.17

Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials. Am J Respir Crit Care Med (2012) 2.15

Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep (2003) 2.13

Climate change and infectious diseases in North America: the road ahead. CMAJ (2008) 2.10

SARS among critical care nurses, Toronto. Emerg Infect Dis (2004) 2.10

Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis. J Crit Care (2012) 2.08

Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis (2004) 2.08

Healthcare-associated influenza in Canadian hospitals from 2006 to 2012. Infect Control Hosp Epidemiol (2014) 2.06

Reducing time-to-treatment decreases mortality of trauma patients with acute subdural hematoma. Ann Surg (2011) 2.06

Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis (2005) 2.03

Modelling mitigation strategies for pandemic (H1N1) 2009. CMAJ (2009) 2.01

Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis. J Infect Dis (2012) 2.00

A practical approach to evidence-based dentistry: IX: how to appraise and use an article about economic analysis. J Am Dent Assoc (2015) 1.99

Social contact networks and disease eradicability under voluntary vaccination. PLoS Comput Biol (2009) 1.96

Evolving public perceptions and stability in vaccine uptake. Math Biosci (2006) 1.96

SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis (2004) 1.95

Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med (2013) 1.94

Incremental health care costs for chronic pain in Ontario, Canada: a population-based matched cohort study of adolescents and adults using administrative data. Pain (2016) 1.94

Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis (2002) 1.93

Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis. J Clin Oncol (2012) 1.90

Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol (2005) 1.90

Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. Arch Intern Med (2012) 1.86

Risk of infection following a visit to the emergency department: a cohort study. CMAJ (2012) 1.83

Lack of comprehension of common prostate cancer terms in an underserved population. J Clin Oncol (2009) 1.82

Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology (2010) 1.80

The effect of English language proficiency on length of stay and in-hospital mortality. J Gen Intern Med (2004) 1.80

Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken) (2011) 1.79

Organ donation after death in Ontario: a population-based cohort study. CMAJ (2013) 1.79

Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res (2009) 1.78

High-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis. Crit Care Med (2010) 1.77

Clostridium difficile infection in hospitals: a brewing storm. CMAJ (2004) 1.74

Update on herpes zoster vaccination: a family practitioner's guide. Can Fam Physician (2011) 1.74

Determination of neurologic prognosis and clinical decision making in adult patients with severe traumatic brain injury: a survey of Canadian intensivists, neurosurgeons, and neurologists. Crit Care Med (2013) 1.72

Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study. CMAJ (2011) 1.72

Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother (2007) 1.72

Influenza vaccination coverage across ethnic groups in Canada. CMAJ (2012) 1.71

Alternative methods of estimating an incubation distribution: examples from severe acute respiratory syndrome. Epidemiology (2007) 1.70

Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting. Diabetes Care (2004) 1.70

Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf (2011) 1.69

Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada. Arch Intern Med (2003) 1.67

Knowledge translation in critical care: factors associated with prescription of commonly recommended best practices for critically ill patients. Crit Care Med (2007) 1.62

Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital. Infect Control Hosp Epidemiol (2005) 1.61

The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review. Vaccine (2011) 1.61

Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J Clin Microbiol (2005) 1.61

Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med (2011) 1.58

Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med (2006) 1.57

Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest (2014) 1.57

A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy. J Infect Dis (2007) 1.56

The influence of social norms on the dynamics of vaccinating behaviour for paediatric infectious diseases. Proc Biol Sci (2014) 1.55

Pay for performance in the intensive care unit--opportunity or threat? Crit Care Med (2009) 1.55

Utility-based Quality of Life measures in Alzheimer's disease. Qual Life Res (2006) 1.55

Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection. J Infect Dis (2008) 1.53

Coverage with evidence development: the Ontario experience. Int J Technol Assess Health Care (2011) 1.53

Knowledge translation interventions for critically ill patients: a systematic review*. Crit Care Med (2013) 1.53

Modelling an influenza pandemic: A guide for the perplexed. CMAJ (2009) 1.53

Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome. J Urol (2006) 1.53

Effect of multivitamin and mineral supplementation on episodes of infection in nursing home residents: a randomized, placebo-controlled study. J Am Geriatr Soc (2007) 1.52

Improving use of targeted temperature management after out-of-hospital cardiac arrest: a stepped wedge cluster randomized controlled trial. Crit Care Med (2015) 1.52

Stray dog population demographics in Jodhpur, India following a population control/rabies vaccination program. Prev Vet Med (2010) 1.51

Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. CMAJ (2004) 1.50